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Summary
We describe a completely in vitro high-throughput
screening system for directed evolution of enzymes
based on in vitro compartmentalization (IVC). Single
genes are transcribed and translated inside the aque-
ous droplets of a water-in-oil emulsion. Enzyme activ-
ity generates a fluorescent product and, after conver-
sion into a water-in-oil-in-water double emulsion,
fluorescent droplets are sorted using a fluorescence-
activated cell sorter (FACS). Earlier in vivo studies
have demonstrated that Ebg, a protein of unknown
function, can evolve to allow Escherichia coli lacking
the lacZ b-galactosidase gene to grow on lactose.
Here we demonstrate that we can evolve Ebg into
an enzyme with significant b-galactosidase activity
in vitro. Only two specific mutations were ever seen
to provide this improvement in Ebg b-galactosidase
activity in vivo. In contrast, nearly all the improved
b-galactosidases selected in vitro resulted from differ-
ent mutations.
Introduction
Directed evolution is a powerful technique for the engi-
neering of enzymes. It is based on mimicking nature
by performing iterative rounds of mutation/recombina-
tion and selection in the laboratory [1].
All evolutionary systems, whether in nature or in the
laboratory, require a link between genotype (a nucleic
acid that can be replicated) and phenotype (a functional
trait such as a binding or catalytic activity). In addition,
there has to be selective pressure for the desired pheno-
type.
In the laboratory, genotype-phenotype linkage is fre-
quently achieved by physically linking genes to the pro-
teins they encode by a variety of techniques, including
display on phage, viruses, bacteria, and yeast, plasmid
display, ribosome display, CIS display, and mRNA-
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F-67083 Strasbourg Cedex, France.peptide fusion. These ‘‘display technologies’’ have
proven highly successful in the generation of binding
proteins but have met with much less success selecting
enzymes. Indirect selections—by binding to transition
state analogs or enzyme inhibitors—have generally
failed to produce potent catalysts [2]. Single-turnover,
intramolecularselections ofenzymesdisplayed onphage
were demonstrated but these impose severe limitations,
not least because selection is not directly for catalysis
[2, 3]. To evolve proficient enzymes, the selection (or
screen) should be simultaneous and direct for all enzy-
matic properties: substrate recognition, formation of a
specific product, rate acceleration, and turnover.
In nature, linkage of genotype to phenotype is
achieved by compartmentalization of genes in cells,
and the selection of cells for a desired phenotype has
also been used very successfully for directed evolution
of proteins. Unfortunately, in vivo selections are usually,
but not always (e.g., [4]), restricted to functions that af-
fect the viability of the organism and are often compli-
cated by the complex intracellular environment. In addi-
tion, there is often no selection system available for the
desired activity.
Hence, directed evolution of enzymes frequently re-
lies, not on selection, but on high-throughput screening
(HTS) using chromogenic or fluorogenic substrates.
However, when screening colonies on agar plates, or in-
dividual clones in microtiter plate wells, typically 103–104
clones,and rarely more than105 clones,canbescreened,
even using sophisticated automated systems [3].
One way of greatly accelerating HTS is to use fluores-
cence-activated cell sorting (FACS), which can routinely
sort >107 clones per hour, and has a series of other ad-
vantageous features [5]. FACS has already proven
a highly successful technique to select proteins (notably
antibodies) with high binding affinities [6–13]. In addi-
tion, FACS has significant potential to select for cataly-
sis [3, 14]; however, so far, this approach has only
been possible when the diffusion of product out of the
cell can be restricted (e.g., [15]), or the product can be
captured on the surface of the cell [16, 17], or onto mi-
crobeads [18].
We have developed a method for directed evolution,
termed in vitro compartmentalization (IVC), which uses
compartmentalization to link genotype and phenotype.
However, instead of compartmentalizing genes in cells,
as in nature, in IVC the genes are compartmentalized in
aqueous microdroplets dispersed in a water-in-oil (w/o)
emulsion [19]. IVC has been used to select proteins for
catalysis [18, 20–24], binding [25–28], and regulation
[29]. The common feature of previous IVC selections
is that the product always ends up linked to the gene,
either directly or via a microbead, and it is the genes
themselves that are selected after breaking of the emul-
sion.
We have previously demonstrated that fluorescent
aqueous droplets in w/o emulsions can be sorted using
FACS and can be recovered intact without losing their
contents if the primary w/o emulsion is first converted
into a w/o/w double emulsion [30]. Here we demonstrate
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pletely in vitro double emulsion selection system based
on IVC (Figure 1) in which the unbroken emulsion drop-
lets are sorted, together with the genes they contain, us-
ing FACS. Single genes are transcribed and translated
in vitro, compartmentalized in aqueous droplets in w/o
emulsions together with a fluorogenic substrate. After
conversion into a w/o/w double emulsion, fluorescent
droplets are sorted using FACS.
The technique relies on using fluorogenic substrates,
which are available for many different enzymes, and
there is no need for the product of the enzymatic reac-
tion to be coupled to genes, cells, or microbeads to al-
low selection.
We have used this double emulsion selection system
for the in vitro evolution of the Ebg enzyme of Escheri-
chia coli. The Ebg system has been used extensively
over the past 3 decades as a model to study the evolu-
tion of novel enzyme functions in vivo [31–33]. These
studies demonstrated that Ebg, an E. coli protein of un-
known function and possessing negligible b-galactosi-
dase activity, can evolve into an active b-galactosidase
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Figure 1. Selection of Double Emulsion Microdroplets Using a Fluo-
rescence-Activated Cell Sorter (FACS)
An in vitro transcription/translation reaction mixture containing a li-
brary of genes encoding mutant enzymes is dispersed to form a
water-in-oil (w/o) emulsion with typically one gene per aqueous
microdroplet (1). The genes are transcribed and translated within
their microdroplets (2). Proteins with enzymatic activity convert the
nonfluorescent substrate into a fluorescent product and the w/o
emulsion is converted into a water-in-oil-in-water (w/o/w) emulsion
(3). Fluorescent microdroplets are separated from nonfluorescent
microdroplets (or microdroplets containing differently colored fluo-
rochromes) using a fluorescence-activated cell sorter (FACS) (4).
Genes from fluorescent microdroplets, which encode active en-
zymes, are recovered and amplified using the polymerase chain re-
action (5). These genes can be recompartmentalized for further
rounds of selection (6).that can replace the function of the LacZ b-galactosi-
dase. All mutants which could grow on lactose con-
tained either a D92N substitution (class I mutants),
a W976C substitution (class II mutants), or a combination
of the two substitutions (class IV mutants).
In vitro evolution of Ebg using double emulsion IVC
generated b-galactosidases which contained com-
pletely different mutations from those seen in all im-
proved Ebg b-galactosidases evolved in vivo.
As described in the accompanying manuscript [34],
FACS sorting of double emulsions also allows the selec-
tion of single bacterial cells which are compartmental-
ized in the internal aqueous droplets together with a flu-
orogenic substrate. This technique was used for the
directed evolution of serum paraoxonase (PON1) with
improved thiolactonase activity.
FACS of double emulsions, therefore, has the poten-
tial to greatly expand the range of enzymes that can be
screened, using both in vitro and in vivo systems.
Results
Preparation and Characterization
of Double Emulsions
In order to select as outlined in Figure 1, the emulsions
should: (1) allow efficient transcription and translation;
(2) be stable throughout the selection procedure (includ-
ing flow sorting); (3) compartmentalize the gene-
encoded proteins and the fluorescent reaction product;
and (4) the majority of oil droplets should contain no
more than a single aqueous droplet to prevent coselec-
tion of genes that do not encode for active b-galactosi-
dases.
We have previously demonstrated that mineral oil-
based w/o emulsions prepared with 10% aqueous vol-
ume fraction, 4.5% Span 80, and 0.48% Tween 80 can
be re-emulsified with an equal volume of water phase
(2% Tween 20 in PBS) to generate w/o/w double emul-
sions which can be sorted by FACS, while the contents
of the aqueous droplets of the primary w/o emulsion re-
main intact [30].
However, although mineral oil-based w/o emulsions
prepared with 4.5% Span 80 and 0.48% Tween 80 [30],
or with 4.5% Span 80 and 0.5% Triton X-100 [18], al-
lowed transcription and translation (data not shown),
a fluorescence-based aqueous contents exchange as-
say [35] showed rapid exchange of small molecules be-
tween the aqueous droplets of w/o emulsions (see
Figure S1 in Supplemental Data available with this article
online).
We therefore investigated a variety of other formula-
tions. The most suitable involved first making a w/o
emulsion comprising the in vitro coupled transcription/
translation mix (which forms the inner aqueous phase)
and 1% (w/v) Span 60 and 1% (w/v) cholesterol in dec-
ane (which forms the oil phase). The w/o emulsion was
then re-emulsified with 0.5% (w/v) Tween 80 in PBS to
create a w/o/w emulsion with a continuous aqueous
outer phase of PBS (Figure 2). The fluorescence-based
aqueous contents exchange assay [35] showed little ex-
change of small molecules between the aqueous drop-
lets (<4% after 2 hr incubation at 37ºC) (Figure S1).
To confirm that genes, the proteins they encode, and
the fluorescent product are retained within the emulsion
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1293droplets during the sorting process, a model selection
for b-galactosidase activity was performed as de-
scribed in Figure 1 using a fluorogenic substrate, fluo-
rescein di-b-D-galactopyranoside (FDG). lacZ genes
(encoding E. coli b-galactosidase) were enriched from
a pool of frameshifted lacZmut genes (encoding an inac-
tive protein). The lacZ genes were enriched 138-fold
from a 1:1000 molar ratio of lacZ:lacZmut genes (Fig-
ure S2; Table S1).
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Figure 2. Water-in-Oil-in-Water Double Emulsions
Internal water droplets contain 4 mM fluorescein dextran (mw
500,000) and 30 mM BSA in PBS.
(A) A differential interference contrast micrograph of a double emul-
sion.
(B) A confocal epifluorescent micrograph of the same emulsion.
Size bars represent 10 mm.
(C) The size distribution of aqueous droplets in the w/o/w double
emulsion determined using single-particle optical sensing (by per-
centage of total volume).
The mean diameter of the oil droplets in the double emulsions is
4.7 mm.Distinguishing Differences in b-Galactosidase
Activity by Flow Cytometry of Double Emulsions
Genes encoding several b-galactosidases with different
catalytic efficiencies were used to assess the dynamic
range of the system. Wild-type Ebg has negligible b-
galactosidase activity with FDG as substrate. Ebg class
I and class II mutants both have significant and similar
levels of activity (with class II marginally the more effi-
cient). Ebg class IV mutants hydrolyze FDG more effi-
ciently again, but are still significantly less efficient
than E. coli LacZ (Table 1).
Linear DNA constructs encoding wild-type Ebg, class
I mutant, class II mutant, class IV mutant [36], or LacZ
were entrapped inside aqueous compartments of dec-
ane w/o emulsions together with an in vitro translation
system and FDG. After a 2 hr incubation at 30ºC, the
w/o emulsions were converted into w/o/w double emul-
sions and analyzed by flow cytometry (Figure 3). Under
these conditions, there are large fluorescence differen-
ces between wild-type Ebg, Ebg class I, Ebg class IV,
Table 1. Kinetic Analysis of LacZ, Wild-Type Ebg, and Mutated
Variants Using FDG
Enzyme
Relative kcat
(RFU s21) KM (mM)
kcat/KM
(RFU s21 mM21)
wt N.D. >4000 0.0315
EbgMut2a-C10 0.68 60.06 24 68 28.3
EbgMut2a-D1 0.42 60.06 7.9 65 53.2
EbgMut2a-D3 0.66 60.04 34 66 19.4
EbgMut2a-D5-2 0.29 60.01 29 65 10.0
EbgMut2a-D6 0.43 60.04 17 65 25.3
EbgMut2b-E4 0.44 60.02 21 62 21.0
EbgMut2b-E7-2 0.56 60.03 28 65 20.0
EbgMut2b-E8 0.43 60.02 24 64 17.9
Class I 1.8 60.05 510 626 3.53
Class II 1.5 60.08 260 630 5.77
Class IV 3.6 60.44 29 612 124
wt (DebgC) 0.49 60.06 15 65 32.7
Class I (DebgC) 0.74 60.05 12 63 61.7
Class II (DebgC) 0.54 60.04 110 622 4.91
Class IV (DebgC) 1.0 60.05 53 69 18.9
LacZ 187 68.5 150 616 1250
RFU, relative fluorescence units. N.D., not determined.
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Figure 3. Discriminating Wild-Type Ebg, Class I, Class II, and Class
IV Mutants, and LacZ in Double Emulsions Using Flow Cytometry
Genes encoding wild-type, class I, class II, or class IV Ebg and
LacZ were translated for 2 hr at 30ºC cocompartmentalized in
a w/o emulsion with the fluorogenic substrate FDG and 7-hydroxy-
coumarin-3-carboxylic acid. The sorter was triggered on coumarin
fluorescence, thereby ignoring all o/w droplets (i.e., droplets lack-
ing an internal aqueous phase). The levels of product fluorescence
in oil droplets which contain internal aqueous droplets (gated on
coumarin fluorescence) are plotted as histograms (250,000 events).
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Figure 4. Selection of ebg Libraries
A randomly mutated library of ebgAC genes was selected as in Figure 1 using FDG as substrate.
7-hydroxycoumarin-3-carboxylic acid was cocompartmentalized with the genes and the levels of coumarin fluorescence and product fluores-
cence are displayed as dot-plots for each selection round. Only double emulsion compartments which contained 7-hydroxycoumarin-3-car-
boxylic acid were analyzed, allowing us to consider only w/o/w droplets (i.e., droplets having an internal aqueous phase). Sort gates were set
in such a way that less than 0.01% of the double emulsion compartments of a negative control (double emulsions without DNA) was collected
and nearly all of the double emulsion compartments of a positive control (Ebg class IV mutant). For each round of selection, 105 positive events
were collected.
(A) Unselected library.
(B) Library after one round of selection.
(C) Library after two rounds of selection.and LacZ, but the Ebg class I and class II mutants cannot
be resolved.
Selection of ebg Gene Libraries for b-Galactosidase
Activity
Constructs containing both the wild-type ebgA and
ebgC genes, encoding the a domain and b domain of
the Ebg enzyme, were randomly mutated by error-prone
PCR [37], creating a library (EbgMut1) with an average of
4 6 2 mutations per gene, of which 96.7% were transi-
tions.
The library was selected as in Figure 1 using FDG as
substrate. For each selection round, 105 positive events
were collected and the DNA was amplified by PCR. Flow
cytometry analysis of the double emulsion before sort-
ing and after the first and second selection rounds are
shown in Figure 4. Before selection, the percentage of
positive droplets is very low (0.25%) but increases with
each selection round up to 11%.
After two rounds of selection, the library was further
mutated [37] to generate a new library (EbgMut2a) with
an average of 96 2 mutations per gene, and recombined
by DNA shuffling [38], generating EbgMut2b, which con-
tains 12 6 3 mutations per gene. The libraries were se-
lected for two rounds as above, but using more stringent
sort gates.
Analysis of Selected Mutants from the First Round
of Directed Evolution
Three hundred sixty-six clones from the selected
EbgMut1 library were in vitro translated and assayed
for FDG hydrolysis in 384-well plates using 0.1 mM FDG.
Thirty percent had initial rates higher than wild-type Ebg
enzyme, from which 50% were comparable to the class I
mutant and 10% to the class II mutant. None of the
clones had activity higher than the class II mutant.
Sequencing of the 20 mutants with the highest activity
revealed that 13 had mutations in ebgC leading to thepremature termination of translation of the b subunit
(Table 2, A). Moreover, two of these variants contained
no mutations in the ebgA gene encoding the a subunit.
A class I mutation (D92N) was observed in one variant
but no class II mutations (W976C) were found. However,
four variants containing an S975P mutation adjacent to
the class II mutation were selected. The fact that the
W976Camino acidsubstitution was notobservedmay be
due to the bias for transition in the libraries because only
a transversion event could generate this substitution.
Analysis of Selected Mutants from the Second
Round of Directed Evolution
After selection, 1536 clones from the EbgMut2a (mu-
tated) library, and 550 clones from the EbgMut2b (re-
combined) libraries, were in vitro translated and assayed
for FDG hydrolysis as above. Sixty-eight percent of the
EbgMut2a clones, and 41% of the EbgMut2b clones,
had activities higher than wild-type Ebg. The majority
of variants had activities higher than, or comparable
to, the class I mutant (90% for EbgMut2a) and the aver-
age activity of the clones was significantly higher than
those from the selected EbgMut1 library.
Individual clones (4% for each library) were selected
based on their initial rates at 0.1 mM FDG and assayed
to evaluate their Vmax and KM values. Forty-three percent
of these clones had Vmax/KM values comparable to or
higher than class II and 28 were used for further analysis.
Fifty percent contained an early stop codon in the ebgC
gene (Table 2, B). Of these, one third also contained the
S975P mutation. Two other mutations were also ob-
served frequently: S741C and N304D.
The presence of so many variants with frameshifts or
stop codons in ebgC is partly explained by kinetic stud-
ies of wild-type Ebg and the class I, II, and IV mutants in
which the ebgC gene is deleted (Table 1). Unlike wild-
type Ebg, Ebg lacking the b domain encoded by ebgC
shows significant FDG hydrolysis activity with a kcat/KM
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ebgA ebgC
A1
EbgMut1-A3 H73R/A458V/S691P E50Stop
EbgMut1-B9 V243A/T272A/Y824C/C1003R Q76Stop
EbgMut1-A8 none I45T/L63F/FS77/88Stopa
EbgMut1-B6 none I13T/Y100Stop
EbgMut1-E10 P17S/T1006A Q9Stop
EbgMut1-H6 K301R I13T/Y100Stop
EbgMut1-D11 V986I Q76Stop
EbgMut1-C8 Q29R/I211V/F764L/F1019L S16P/S44P/Y100Stop
EbgMut1-B3 E222G/I537P T46Stop
EbgMut1-D6 V201A/Y502H/N573S W20Stop
EbgMut1-A7 M79V/V280A/K436R/Y731C/S741G/N944S Q21Stop
EbgMut1-H5 Q89R Q73Stop
EbgMut1-G11 Q89R E8Stop
EbgMut1-A12 H461R/K761R/S975P/F988L A123V/FS135/182Stopa
A2
EbgMut1-C1 V166A/S975P V110A
EbgMut1-F11 W889C/S975P NO
EbgMut1-G3 C226N/T623A/T624A/F764L/S975P NO
EbgMut1-G9 A465T/E1027G V132A
EbgMut1-C12 T443I I41T/P66l
EbgMut1-G8 D92N/H783N/I811T/Q1030H M1L/I3V
B1
EbgMut2a-C7 D54A/N835D/S975P FS77/88Stopa
EbgMut2a-D5-2 A34T/T228A/E281G/A916T/N1028S Q76stop
EbgMut2a-F10 T703A W20Stop
EbgMut2a-F11-2 I7F/H51R/A69V/I735V/I849V Q12Stop
EbgMut2a-D6 T167A/N236S/N304D/I329V/S741C/S975P FS77/88Stopa
EbgMut2a-D3 K422Q/S741C/S975P FS77/88Stopa
EbgMut2a-D1 A158T/V201A/P698S/Q955R/S975P Q21Stop
EbgMut2a-G11 E498K/I582V/H605R/A830V R22H/R63Stop
EbgMut2a-B5 M335T/L719P W20Stop
EbgMut2b-E3-2 W13S/F103S/N702D/N908S/S975P/S1026G D5G/T46P/Y65P/Y100Stop
EbgMut2b-E7-2 S741C/S975P C23R/R63Stop
EbgMut2b-D11 N237S/N304D/I329V/W826C/D864E W20Stop
EbgMut2b-E4 D92N/D302G/N304D/A867V/G1018V Q9Stop
EbgMut2b-A8 D97G/E639D/T745A/D793G/M857V Q73Stop
B2
EbgMut2a-C10 E498K/Q881R/S975P F10S/C23R/E90G
EbgMut2a-D5 S39R/Q282R/E476G/E498K/Q881R/S975P F10S/C23R
EbgMut2a-F9 N2S/Q282R/C452R/E498K/Q881R/S975P F10S/C23R
EbgMut2a-C4 N2S/W123S/Q282R/E498K/Q881R/S975P F10S/C23R
EbgMut2a-F7 N2S/Q282R/E498K/C725Y/Q881R/S975P F10S/C23R
EbgMut2a-C11 N2S/Q282R/E498K/Q881R/S975P F10S/C23R
EbgMut2a-C5 N2S/Q282R/E498K/Q881R/S975P F10S/C23R
EbgMut2a-C8 Q282R/E498K/V727I/Q881R/S975P F10S/C23R
EbgMut2a-G9 C225R/S975P L45S/T96I/N130D
EbgMut2a-G7 K270R/V334A/M766V/N782S/S975P NO MUTATION
EbgMut2a-G4 N2S/Q282R/E498K/Q881R/M911Y/S975P F10S/C23R
EbgMut2a-B2 I116T/N331D/Q366R/P494L/E701D/K743R/T918A D36G/Y46H/D56G/I127T/T40A
EbgMut2b-D8 N2S/V104A/Q282R/E498K/R692H/D722G/Q881R/S975P F10S/C23R/K83R
EbgMut2b-E8 F383L/T398A/Q881R/S975P F10S/K18R/C23R/C118Y
(A) First-generation mutants.
(B) Second-generation mutants.
(A1 and B1) Mutants with an ebgC gene containing a deletion or a point mutation leading to a stop codon.
(A2 and B2) Mutants containing a full-length ebgC. Amino acid positions found mutated more than once are shown in bold. The D92N mutation,
observed in previous in vivo studies, is in italics.
a Location of frameshift (FS) and resulting stop codon (Stop).higher than the class I and II mutants. This is mainly due
to a large decrease in KM, which is also observed in the
class I mutant with ebgC deleted.
In the clones encoding a full-length b domain, some
mutations appeared with high frequency. In the a sub-
unit, 13 variants contained the S975P mutation, 11 of
which contained an additional Q881R mutation, 10 an
E498K mutation, 9 a Q282R mutation, and 7 an N2S mu-tation. Interestingly, three mutations were also con-
served in the b subunit: 11 mutants contained the muta-
tions F10S and C23R.
Eight mutants were selected for further kinetics anal-
ysis (Table 1). They all had kcat/KM values at least 300-
fold higher than wild-type Ebg, which showed very little
activity with FDG as substrate and had a very high KM
of >4 mM. The catalytic efficiencies (kcat/KM) of all eight
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tosidase
The model was constructed by homology
modeling using the structure of the LacZ
b-galactosidase (Protein Data Bank code
1JZ7), with galactose in the binding site, as
template [39]. The alignment between ebgA
and the lacZ genes was recovered from the
blast search that identified the template. The
alignment of lacZ and the genes belonging
to the same family as ebgA given by the
ExPASy website (see http://us.expasy.org/
cgi-bin/niceprot.pl?P06864) was used to de-
fine the highly conserved residues, which
were all correctly aligned in the pairwise align-
ment. The residues of the model superim-
pose well with those of the template (rmsd =
0.67 A˚), in particular those of the active site.
One a subunit is shown in cartoon represen-
tation. The magnesium ions, sodium ions,
and galactoses are shown in cyan. The model shows the location of residues which were frequently substituted in selected variants. Residues
close to the galactose in the active site (less than 5 A˚) are shown in blue and W976 in dark blue. The other residues are at the surface of the
monomer: those at the interface between monomers are shown in pink (N2 and E498) and those facing the solvent in yellow (Q282, N304,
S741). Residue Q881 is located less than 10 A˚ from the second galactose (which is not in the active site) and is shown in violet.mutants were between those of class II and class IV mu-
tants. All eight mutants had very similar relative kcat val-
ues of around 0.5 RFU s21, slightly lower than the class I,
II, and IV mutants, but with low KM values of around 20
mM, comparable to class IV. This is consistent with the
relatively low substrate concentrations used for selec-
tion and screening (0.5 mM and 0.1 mM FDG, respec-
tively). A model of the EbgA subunit was constructed
by homology modeling using the structure of the LacZ
b-galactosidase [39] (Figure 5). All the frequently mu-
tated amino acids in ebgA, except S975, seem to be
on the surface of the monomer, suggesting a role in in-
teraction between the subunits.
Discussion
We have developed a completely in vitro high-through-
put screening (HTS) strategy for directed evolution of
enzymes. This method is based on in vitro compartmen-
talization (IVC) of genes in aqueous microdroplets dis-
persed in a water-in-oil (w/o) emulsion [19]. IVC has pre-
viously been used to select proteins for catalysis [18,
20–24], binding [25–28], and regulation [29] using a for-
mat in which the product ends up linked to the gene,
either directly or via a microbead, and it is the genes
themselves that are selected after the breaking of the
emulsion.
Here we describe an adaptation of the IVC system in
which it is the unbroken emulsion droplets which are
sorted by FACS, together with the genes they contain
(Figure 1). The technique relies on using fluorogenic
substrates, which are available for many different en-
zymes and which do not need to be coupled to the
gene to allow selection. In order to allow the sorting of
fluorescent droplets by FACS, the primary w/o emulsion
is converted into a w/o/w double emulsion [30]. This
technique greatly expands the range of enzymes that
can be selected using IVC. We have demonstrated the
use of this double emulsion selection system for the
in vitro evolution of a b-galactosidase.The evolution of b-galactosidase genes in Escherichia
coli has proven to be an excellent model system to dy-
namically study the evolution of novel enzyme functions
in vivo (for reviews, see [31–33]). Three decades ago, it
was demonstrated that E. coli strains from which the
lacZ b-galactosidase gene had been deleted (DlacZ
strains) could evolve under selective pressure into var-
iants that can grow with lactose as the only carbon
source [40, 41]. Further studies revealed that this is due
to the evolution of the ebg operon. The ebg operon con-
sists of four genes: ebgR encodes a repressor that regu-
lates the expression of ebgABC; ebgB encodes a protein
whose function is unknown but which is structurally re-
lated to transport proteins; ebgA encodes the 118 kDa
a subunit and ebgC the 20 kDa b subunit of the a4b4
Ebg enzyme, the natural function of which is unknown.
Wild-type Ebg enzyme has 31% protein homology with
LacZ b-galactosidase but is a very feeble b-galactosi-
dase and cannot support growth of DlacZ strains on lac-
tose, even if the enzyme is constitutively expressed at
levels up to 5% of total cellular protein [31].
Selection for spontaneous lactose-utilizing mutants
from DlacZ ebgR2 (constitutive) strains results in muta-
tions in ebgA and produces only two classes of mutants:
all class I mutants have a D92N substitution, while all
class II mutants have a W976C substitution. The combi-
nation of the two substitutions (class IV mutants) further
increases catalytic efficiency and expands the substrate
range of the enzyme.
EbgA is part of an ancient clade of functional b-galac-
tosidase that diverged from the paralogous LacZ
b-galactosidase over 2 billion years ago [33]. In that
time, EbgA has acquired a new, and unknown, function.
EbgA differs from other members of its clade at only
2 of the 15 active site residues, and the two mutations
required to bring it into line with the other clade mem-
bers are the two substitutions found in the class IV mu-
tant. This led to the conclusion that either these are
the only acceptable amino acid substitutions to give
b-galactosidase activity, or that all of the single point
mutations that must arise as intermediates on pathways
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deleterious [33].
The results obtained in vitro using IVC were quite dif-
ferent from those from in vivo studies: of the evolved 48
mutants with significant b-galactosidase activity, only 2
contained the D92N substitution (class I) and none con-
tained the W976C substitution (class II). Instead, a vari-
ety of alternative solutions are seen (Table 2). Particu-
larly striking was the observation of many clones with
mutations leading to frameshifts or stop codons in the
ebgC gene, which encodes the small b subunit of the
a4b4 Ebg enzyme. Mutations in ebgC which remove
the b subunit have never been observed during in vivo
evolution experiments. The b subunit is an enigma; there
is only one homolog in GenBank which encodes a hypo-
thetical enzyme of unknown function, and no other
b-galactosidases in the same family as Ebg and LacZ
are known to be heteromultimers. The b subunit does
not contain any active site residues, but loss of the b sub-
unit reduces the rate-determining degalactosylation
step in catalysis by 200-fold for the wild-type enzyme
and 20-fold for the class I enzyme [42].
The fact that loss of the b subunit was never observed
in the in vivo studies could be due to the fact that the
b domain performs an important and unknown role in
E. coli, creating a strong selective pressure to maintain
the b domain. However, this seems unlikely, because
loss of Ebg appears to have no ill effects on E. coli in
the laboratory.
A clear difference between the in vivo studies and
those presented here is that the substrates used for
the in vivo selections were either lactose, lactulose, ga-
lactosyl-D-arabinose, or lactobionate, whereas in this
study the substrate was FDG. Indeed, deleting the b sub-
unit from wild-type Ebg results in a significant improve-
ment of the FDG hydrolysis activity (Table 1).
Another difference between the selections by IVC and
the in vivo studies is the mutation rate. In vivo, it would
be extremely rare for the ebg gene to contain more
than a single mutation, whereas in this study there
were 4, 9, or 12 mutations per gene in the different librar-
ies selected. This allows access to a region of sequence
space that was not accessible in vivo.
We have demonstrated that, by using a fluorogenic en-
zyme substrate and flow sorting of double emulsions, it
is possible to evolve an enzyme (Ebg) completely in vitro.
In the case of Ebg, it would also have been possible to
undertake a similar directed evolution experiment in vivo
using FDG as a fluorogenic substrate and screening cells
by FACS: libraries of ebgA and ebgC genes, mutated in
vitro, could be transforming into E. coli in which the
lacZ, ebgA, and ebgC genes were deleted. Indeed, flow
cytometric assays of b-galactosidase in bacterial, yeast,
and mammalian cells have been used quite extensively
[43–48].
However, the in vitro double emulsion still has some
advantageous features for directed evolution: multiple
cycles of mutation/recombination and selection can be
performed quickly, as there is no need to transform cells
with DNA; the fluorogenic substrates do not have to pen-
etrate cells; there is no requirement for the product to re-
main inside or be captured on the surface outside of
cells; there are no constraints related to the need to re-
tain the original function of the enzyme; enzymatic activ-ities can be screened which would be toxic to a cellular
host; and the use of highly purified cell-free translation
systems [49] should greatly reduce the risk that endog-
enous enzyme activities will act on the substrate.
For some projects, the expression of enzymes in cells
may still be advantageous. In such cases, when it is not
possible to sort the cells directly by FACS, it is also pos-
sible to compartmentalize the cells in double emulsions,
together with a fluorogenic assay system, and sort the
double emulsions by FACS, as described in the accom-
panying manuscript [34].
We believe that HTS of double emulsions by FACS, as
described in this and the accompanying manuscript
[34], is a potentially powerful tool for directed evolution,
both due to the speed of screening (>107 variants per
hour) and the broad dynamic range. Indeed, flow cytom-
etry of double emulsions can easily distinguish between
wild-type Ebg, Ebg class I, Ebg class IV, and LacZ (Fig-
ure 3). Only the Ebg class I and class II mutants cannot
be resolved. Furthermore, the ability to perform multipa-
rameter flow sorting opens up the possibility of simulta-
neously selecting enzymes with two or more substrates,
each of which is hydrolyzed to release a different col-
ored fluorochrome, thereby allowing selection for sub-
strate specificity [17].
Significance
Wehave developed a completely in vitro high-through-
put screening (HTS) system (>107 hour21) for the di-
rected evolution of enzymes based on FACS. We
have previously described a system to select for catal-
ysis based on in vitro compartmentalization (IVC) of
genes in aqueous droplets in w/o emulsions [18–21,
24]. Here, we describe an adaptation of the IVC system
based on HTS using fluorogenic substrates. The w/o
emulsion is converted into a w/o/w double emulsion,
and fluorescent droplets are sorted by FACS. Due to
its speed, sensitivity, and dynamic range, HTS of cells
by FACS has proven a powerful technique to screen
proteins for binding and catalysis. However, as HTS
of double emulsions is a completely in vitro system,
multiple cycles of mutation/recombination and selec-
tion can be performed quickly, and enzymatic activi-
ties which are toxic to a cell can be screened. Further-
more, the range of enzymes that can be selected is
greatly expanded, asmany fluorogenic substrates and
coupled enzyme assays are available and there is no
requirement for the substrate to enter a cell, or for the
fluorescent product to remain inside or trapped on the
surface of a cell (as with in vivo FACS screens) or
linked to the gene (as in earlier examples of IVC). FACS
of cells compartmentalized in double emulsions can
also be used for HTS of enzymes [34].
Here we demonstrate HTS of double emulsions to
evolve Ebg into an enzyme with significant b-galacto-
sidase activity. Earlier in vivo studies have shown that
Ebg, a protein of unknown function, can evolve to al-
low Escherichia coli lacking the lacZ b-galactosidase
gene to grow on lactose. Only two specific mutations
were ever seen to provide this improvement in Ebg b-
galactosidase activity. In contrast, nearly all the b-
galactosidases selected in vitro resulted from differ-
ent mutations.
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Synthesis of lacZ and ebg Genes
pIVEX2.2EM is a truncated version of pIVEX2.2bNde (Roche, Indian-
apolis, IN) lacking part of the LacZ a-peptide coding sequence. The
wild-type E. coli lacZ gene and a variant lacZ gene with a frameshift
mutation that removes an internal SacI site were cloned into
pIVEX2.2EM, creating pIVEX2.2EM-LacZ and pIVEX2.2EM-lacZmut,
respectively. The E. coli ebgA and ebgC genes were cloned as a
single construct into pIVEX2.2EM, creating pIVEX2.2EM-ebgAC
(Figure S3A). The ebg class I, class II, and class IV mutants were
created by site-directed mutagenesis of pIVEX2.2EM-ebgAC. The
deleted variant pIVEX2.2EM-ebgA with a deletion in the ebgC
gene (Figure S3B) and the class I, class II, and class IV variants
with the same deletion were constructed from the corresponding
pIVEX2.2EM-ebgAC plasmids. Linear DNA constructs for in vitro
translation and selection were generated from pIVEX2.2EM con-
structs by PCR. For further details, see Supplemental Data.
Creation of ebg Gene Libraries
A random mutagenesis library (EbgMut1) was constructed by error-
prone PCR of ebg using base analogs essentially as described [37].
After two rounds of selection, the library was remutated following
the same protocol. For further details, see Supplemental Data.
Shuffling of ebg Gene Libraries
EbgMut1 library DNA recovered after the second round of selection
was shuffled essentially as described [38]. For further details, see
Supplemental Data.
Preparation of In Vitro Transcription/Translation Mix
A 50 ml coupled in vitro transcription/translation (IVT) mixture
(EcoProT7; Novagen/EMD Biosciences, Madison, WI), containing
0.1 nM library DNA and supplemented with 500 mM fluorescein
di-b-D-galactopyranoside (FDG; Molecular Probes, Invitrogen,
Carlsbad, CA) and 75 mM 7-hydroxycoumarin-3-carboxylic acid
(Sigma Aldrich, St. Louis, MO), was prepared on ice according
to the manufacturer’s protocol. For model selections with LacZ
b-galactosidase, the final concentration of FDG was 250 mM.
Preparation of Primary (w/o) Emulsions
A solution of 1% (w/v) Span 60 and 1% (w/v) cholesterol in decane
(all from Sigma Aldrich) was prepared at 45ºC, then divided into
200 ml aliquots and placed in a heat block at 37ºC.
A hand-extruding device (mini extruder; Avanti Polar Lipids, Ala-
baster, AL) was fitted with a 19 mm Track-Etch polycarbonate filter
with average pore size of 14 mm (GE Osmonics, Minnetonka, MN) in-
side the mini extruder. Two gas-tight 1 ml Hamilton syringes (Gas-
tight 1001; Hamilton, Reno, NV) were used for extrusion. The ex-
truder was prerinsed with 3 3 1 ml of decane.
For emulsification, 50 ml of IVT mixture was added to 200 ml of the
preheated decane/surfactant mix and loaded into one of the syrin-
ges. The IVT mix was forced through the filter into the alternate sy-
ringe and directly forced back into the original syringe to complete
one round of extrusion. In total, 7.5 rounds of extrusion were com-
pleted. The w/o emulsion formed was placed at 30ºC for 2 hr to allow
in vitro transcription and translation.
Preparation of Secondary (w/o/w) Double Emulsions
For the second emulsification step, a 19 mm Track-Etch polycarbon-
ate filter with an average pore size of 8 mm was fitted inside the ex-
truder. The extruder was prerinsed with 33 1 ml PBS. Two hundred
fifty microliters of the primary w/o emulsion was added to 750 ml of
PBS containing 0.5% (w/v) Tween 80 (Sigma Aldrich) and loaded
into one of the syringes. The IVT mix was forced through the filter
into the alternate syringe and directly forced back into the original
syringe to complete one round of extrusion. In total, 3.5 cycles of ex-
trusion were performed. The double emulsions were collected on
ice. The size distribution of the oil droplets was determined by sin-
gle-particle optical sensing (SPOS) using an AccuSizer 780 optical
particle sizer (Particle Sizing Systems, Santa Barbara, CA).FACS Sorting of Double Emulsions
Double emulsions were diluted 25-fold in sterile-filtered PBS and run
on a MoFlo flow cytometer (DakoCytomation, Fort Collins, CO) using
PBS as sheath fluid. The cytometer was fitted with a 100 mm nozzle,
an argon ion laser emitting at 488 nm, and an argon ion laser tuned at
350 nm. Two band-pass filters of 4506 30 nm and 5306 15 nm were
used to detect the 7-hydroxycoumarin-3-carboxylic acid fluores-
cence and product fluorescence, respectively. The sorter was trig-
gered on coumarin fluorescence, thereby ignoring all o/w droplets
(i.e., droplets lacking an internal aqueous phase). The applied rate
of sorting was 20,000 events per second. Sort gates were set so
as to collect <0.01% of the double emulsion compartments of a neg-
ative control (double emulsions without DNA). For the second-
generation libraries, in the last selection round, the gates were set
to favor mutants with similar kinetics to class IV. One hundred thou-
sand droplets were collected using purify mode in each selection
round.
DNA Recovery from Sorted Double Emulsions
DNA from the sorted w/o/w compartments was precipitated by add-
ing 0.1 volume (relative to the sorted volume) of 3 M sodium acetate
(pH 5.2) and 0.7 volume of isopropanol in the presence of 20 mg gly-
cogen. DNA was pelleted by centrifugation at 20,000 3 g for 15 min
at 4ºC, washed twice with 100 ml 70% ethanol, dried using a
speedvac (Eppendorf, Cambridge, UK), and resuspended into 20 ml
water. Ten microliters of this DNA was used in a 50 ml PCR reaction
using Expand Long Template PCR mix with buffer 1 (Roche). Primers
used after each selection round are described in Table S2. Reactions
were performed using 300 mM primers and incubated for 2 min at
94ºC and subsequently subjected to ten cycles at 94ºC, 15 s;
55ºC, 30 s; 68ºC, 2 min, another 22 cycles with an increment in elon-
gation time of 10 s/cycle, and a final incubation step for 7 min at
68ºC. PCR products were purified using a Qiaquick PCR Purification
kit (Qiagen, Crawley, UK) between selection rounds and by electro-
elution using a GeBAflex dialysis kit (GEBA, Gene Bio-Application,
Kfar Hanagid, Israel) after the last selection round.
Characterization of Selected Clones
Electroeluted DNA recovered after the last selection round of each
cycle of directed evolution was cloned into pIVEX2.2EM (see Sup-
plemental Data). Individual clones were amplified in 10 ml PCR reac-
tions in a 384-well PCR plate (Abgene, Epsom, UK). The amplifica-
tions were performed using Expand Long Template PCR mix
(Roche) with primers PIVB-4 and LMB2-10E, and cycled 32 times
as above. One microliter of the PCR reaction was transferred to 7 ml
of EcoProT7 IVT mix and incubated for 2.5 hr at 30ºC. Three micro-
liters of this reaction mix was transferred to 20 ml of reaction buffer
containing 0.1 mM FDG in a 384-well black microtiter plate (Nunc,
Rochester, NY). Initial rates were measured by monitoring at 25ºC
for 2 hr using a SpectraMAX Gemini XS fluorometer (Molecular Devi-
ces, Sunnyvale, CA) set at excitation 485 nm and emission 514 nm.
Wild-type Ebg and the class I, II, and IV mutants were used as
controls.
Kinetic Analysis of Selected Clones
After the second cycle of directed evolution, 60 clones with initial
rates for 0.1 mM FDG hydrolysis at least two times higher than
Ebg class II were selected from library EbgMut2a (mutated), and
23 were selected from library EbgMut2b (recombined). The initial
rate of FDG hydrolysis was determined at 0.1 mM, 0.2 mM, 0.4
mM, and 0.8 mM FDG to estimate Km and Vmax. The 28 variants
with the higher Vmax/Km were streaked and tested again. The DNA
was extracted and used to retransform E. coli, and single colonies
were assayed to ensure DNA segregation.
Linear DNA constructs encoding the selected mutants and
controls (wild-type Ebg, the class I, II, and IV mutants, and the
corresponding constructs lacking ebgC) were generated from
pIVEX2.2EM constructs by PCR using primers LMB2-10E and
PIVB-4 and the Expand Long Template PCR mix (Roche) (see Sup-
plemental Data). DNA was purified using a Qiaquick PCR Purification
kit (Qiagen). Five nanomolar linear constructs were used in 80 ml
in vitro translation reactions using EcoProT7 IVT mix and incubated
for 4 hr at 30ºC. To measure the KM and Vmax, 4 ml aliquots of the
IVT reaction were assayed in 40 ml reaction buffer at different
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a 384-well black microtiter plate. The kinetic parameters were deter-
mined by fitting the maximum fluorescence rate at each FDG con-
centration to the Michaelis-Menten equation (y = [E]0[S]0kcat/[S]0 +
KM) using the Levenberg-Marquardt algorithm as implemented in
KaleidaGraph (Synergy, Reading, PA) [50] (see Supplemental Data).
Wild-type Ebg showed very little activity with FDG as substrate and it
was not possible to accurately determine the kcat and KM because
activity was only detectable at the highest FDG concentrations
and at the highest FDG concentration achievable (4 mM) activity
had not reached a plateau. Hence, it was only possible to say that
the KM is probably >4 mM and to estimate the kcat/KM from the max-
imum velocity at 4 mM FDG, assuming that [S]0 < KM and y z
[E]0[S]0(kcat/KM).
The protein yield per translation reaction was determined for each
of the selected mutants and controls by measuring incorporation of
[35S]methionine in a 20 ml IVT reaction. Insoluble material was re-
moved by spinning 10 min at 25,000 3 g, and 2.5 ml of the superna-
tant was run on a NuPAGE 10% Bis-Tris gel (Invitrogen) with MES
buffer and full-length protein quantified using a phosphorimager
(Storm 860, Molecular Dynamics). Protein yields varied by 624%.
Supplemental Data
Supplemental Data include three figures and two tables and can
be found with this article online at http://www.chembiol.com/cgi/
content/full/12/12/1291/DC1/.
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